These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 6197456

  • 1. Prophylactic immunization against experimental leishmaniasis. II. Further characterization of the protective immunity against fatal Leishmania tropica infection induced by irradiated promastigotes.
    Howard JG, Liew FY, Hale C, Nicklin S.
    J Immunol; 1984 Jan; 132(1):450-5. PubMed ID: 6197456
    [Abstract] [Full Text] [Related]

  • 2. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
    Liew FY, Howard JG, Hale C.
    J Immunol; 1984 Jan; 132(1):456-61. PubMed ID: 6228580
    [Abstract] [Full Text] [Related]

  • 3. Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection.
    Liew FY, Singleton A, Cillari E, Howard JG.
    J Immunol; 1985 Sep; 135(3):2102-7. PubMed ID: 3160786
    [Abstract] [Full Text] [Related]

  • 4. Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection.
    Liew FY, Hale C, Howard JG.
    J Immunol; 1985 Sep; 135(3):2095-101. PubMed ID: 4020140
    [Abstract] [Full Text] [Related]

  • 5. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
    Scott P, Pearce E, Natovitz P, Sher A.
    J Immunol; 1987 Jul 01; 139(1):221-7. PubMed ID: 3495599
    [Abstract] [Full Text] [Related]

  • 6. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells.
    Liew FY, Hale C, Howard JG.
    J Immunol; 1982 Apr 01; 128(4):1917-22. PubMed ID: 6120976
    [Abstract] [Full Text] [Related]

  • 7. Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization.
    Kahl LP, Scott CA, Lelchuk R, Gregoriadis G, Liew FY.
    J Immunol; 1989 Jun 15; 142(12):4441-9. PubMed ID: 2786033
    [Abstract] [Full Text] [Related]

  • 8. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
    Liew FY, Dhaliwal JS.
    J Immunol; 1987 Jun 15; 138(12):4450-6. PubMed ID: 3295049
    [Abstract] [Full Text] [Related]

  • 9. Protection against Leishmania major in BALB/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes.
    Scott P, Caspar P, Sher A.
    J Immunol; 1990 Feb 01; 144(3):1075-9. PubMed ID: 2295814
    [Abstract] [Full Text] [Related]

  • 10. Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection.
    Howard JG, Nicklin S, Hale C, Liew FY.
    J Immunol; 1982 Nov 01; 129(5):2206-12. PubMed ID: 7119442
    [No Abstract] [Full Text] [Related]

  • 11. Prophylactic immunization against experimental leishmaniasis. VI. Comparison of protective and disease-promoting T cells.
    Liew FY, Hodson K, Lelchuk R.
    J Immunol; 1987 Nov 01; 139(9):3112-7. PubMed ID: 3312413
    [Abstract] [Full Text] [Related]

  • 12. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
    Titus RG, Lima GC, Engers HD, Louis JA.
    J Immunol; 1984 Sep 01; 133(3):1594-600. PubMed ID: 6205088
    [Abstract] [Full Text] [Related]

  • 13. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
    Melby PC, Yang J, Zhao W, Perez LE, Cheng J.
    Infect Immun; 2001 Aug 01; 69(8):4719-25. PubMed ID: 11447143
    [Abstract] [Full Text] [Related]

  • 14. Monoclonal antibodies specific for Leishmania tropica. I. Characterization of antigens associated with stage- and species-specific determinants.
    Jaffe CL, McMahon-Pratt D.
    J Immunol; 1983 Oct 01; 131(4):1987-93. PubMed ID: 6194223
    [Abstract] [Full Text] [Related]

  • 15. Killing of Leishmania tropica amastigotes by factors in normal human serum.
    Hoover DL, Berger M, Nacy CA, Hockmeyer WT, Meltzer MS.
    J Immunol; 1984 Feb 01; 132(2):893-7. PubMed ID: 6690622
    [Abstract] [Full Text] [Related]

  • 16. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.
    Solbach W, Forberg K, Kammerer E, Bogdan C, Röllinghoff M.
    J Immunol; 1986 Jul 15; 137(2):702-7. PubMed ID: 3487578
    [Abstract] [Full Text] [Related]

  • 17. Do sugar residues contribute to the antigenic determinants responsible for protection and/or abolition of protection in Leishmania-infected BALB/c mice?
    Gorczynski RM.
    J Immunol; 1986 Aug 01; 137(3):1010-6. PubMed ID: 2424979
    [Abstract] [Full Text] [Related]

  • 18. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL, Holzmuller P, Gonçalves RB, Bourdoiseau G, Hugnet C, Cavaleyra M, Papierok G.
    Vaccine; 2007 May 22; 25(21):4223-34. PubMed ID: 17395339
    [Abstract] [Full Text] [Related]

  • 19. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK, Naskar K, De T.
    Eur J Immunol; 2009 Aug 22; 39(8):2146-60. PubMed ID: 19593771
    [Abstract] [Full Text] [Related]

  • 20. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
    Prina E, Lang T, Glaichenhaus N, Antoine JC.
    J Immunol; 1996 Jun 01; 156(11):4318-27. PubMed ID: 8666803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.